New Zealand markets close in 6 hours 57 minutes

Rafarma Pharmaceuticals, Inc. (RAFA)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.2040-0.0250 (-10.92%)
At close: 03:46PM EST
Full screen
Trade prices are not sourced from all markets
Previous close0.2290
Open0.1711
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.1711 - 0.2040
52-week range0.1060 - 0.4400
Volume12,994
Avg. volume54,983
Market cap98.245M
Beta (5Y monthly)-0.51
PE ratio (TTM)N/A
EPS (TTM)-0.0140
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Rafarma pharmaceutical updates: agreements with Shri Lanka pharmaceutical company Kelun Lifesciences (Pvt) Ltd and El Salvador University

    Wyoming, USA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA) - We are pleased to announce that Rapharma and its CEO Raivo Unt have entered into a preliminary agreement with Kelun Lifesciences (Pvt) Ltd, a pharmaceutical company based in Sri Lanka, on 17 November 2023. It is Sri Lanka's first and only pharmaceutical manufacturing facility for sterile liquid injections and infusions. The headquarters of the company is based in Kandy on the island of Sri Lanka. Thus, the inte

  • GlobeNewswire

    Rafarma Pharmaceutical news update

    Russia, Moscow, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA). The Company is pleased to announce that it has completed the restructuring, accounting and balance sheet procedures required to comply with GAAP auditing standards. Due to the changed geopolitical situation, the company was unable to complete the review of some of the assets that were set for audit consolidation, namely Kraspharma and Bebig. The Company will continue to provide its shareholders with regular un